Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · ZR2 BIOENERGY LIMITED · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
ZR2 BIOENERGY LIMITED
BSE: 506640
BSE: 506640
Commodities › Chemicals › Chemicals & Petrochemicals › Commodity Chemicals
ZR2 BIOENERGY LIMITED
StateQ4 FY26 filed
Last close · 27 Oct 2026₹115.90
Market cap₹0.0k cr
TTM P/E · P/B · EV/EBITDA41.1 · 0.30 · 19.0
ZR2 BIOENERGY LIMITED is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 1 | 0 |
| EBITDA (ex other income) | (0) | (1) |
| margin % | (26.6) | — |
| Owners' profit | 0 | 0 |
| EPS, as reported (₹) | 0.25 | 2.81 |
| ROE % · ROCE % | 0.1 · 0.1 | 0.7 · 0.7 |
| Debt / equity (x) | 0.00 | 0.00 |
| Cash from operations | 31 | (1) |
| Capex | (119) | (1) |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · ZR2 BIOENERGY LIMITED · 29 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY23 | Q3 FY23 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | (0) | (0) | (1) | 0 | 0 | 0 | 0 | 0 |
| Net profit | (0) | (0) | (1) | 0 | 0 | 0 | 0 | 0 |
| EPS (₹) | (0.04) | (0.19) | (1.54) | 0.32 | 0.86 | 0.76 | 0.64 | 0.56 |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| TATA CHEMICALS LTD | 15,351 | — | 0.69 | 139.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| DEEPAK FERTILIZERS & PETR | 14,679 | 14.9 | 1.97 | 11.1 | 9.9 | 8.4 | 14.6 | 26.1 |
| GUJ NAR VAL FER & CHEM L | 7,529 | 7.3 | 0.83 | 5.4 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,923 | 56.6 | 18.55 | — | 18.8 | 24.3 | — | 16.0 |
| GUJARAT ALKALIES & CHEM | 4,105 | 61.8 | 0.79 | 8.7 | (0.0) | 0.7 | 12.4 | 18.4 |
| GHCL LIMITED | 3,565 | 7.8 | 1.00 | 4.7 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,543 | 21.6 | 3.28 | 14.4 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,179 | 29.0 | 4.03 | 22.2 | 12.7 | 16.9 | — | 11.5 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 41.1 | 17.4 | 42 of 50 | 16% |
| P/B | 0.3 | 1.4 | 4 of 60 | 95% |
| ROCE | 0.7 | 6.0 | 46 of 62 | 26% |
| ROE | 0.7 | 5.0 | 43 of 60 | 29% |
| Debt / Equity | 0.0 | 0.2 | 2 of 60 | 85% |
| Profit growth | 75.9 | 21.0 | 23 of 64 | 65% |
| Market cap | 41 | 98 | 41 of 66 | 39% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · ZR2 BIOENERGY LIMITED · 29 October 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 15 Jul 2026 · Quarterly dematerialisation compliance certificate filed with BSE | compliance | minimal | — | — |
| 19 Jun 2026 · Trading window closed from July 1 ahead of Q1 results | compliance | minimal | — | — |
| 29 May 2026 · This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone .... | results | high | — | — |
| 29 May 2026 · This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone .... | results | high | — | — |
| 28 May 2026 · The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price, in order to ensure that investors have latest relevant information about .... | regulatory legal | medium | — | — |
| 28 May 2026 · The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price, in order to ensure that investors have latest relevant information about .... | compliance | low | — | — |
| 26 May 2026 · ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve In compliance with Regulation .... | results | low | — | — |
| 15 May 2026 · MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH, 2026 | compliance | minimal | — | — |
| 19 Apr 2026 · Dear Sir/Madam, We write to inform you that in accordance with the Company's Code of Conduct for Insider Trading ('Code') read with applicable provisions of SEBI (Prohibition of Insider .... | compliance | minimal | — | — |
| 13 Apr 2026 · Dear Sir/Madam, Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed herewith a confirmation .... | compliance | minimal | — | — |
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in